{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:04:53Z","timestamp":1791453893092,"version":"4.3.3"},"reference-count":83,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T00:00:00Z","timestamp":1593302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Dengue is a devastating viral fever of humans, caused by dengue virus. Using a novel zebrafish model of dengue pathology, we validated the potential anti-dengue therapeutic properties of pentaherbal medicine, Denguenil Vati. At two different time points (at 7 and 14 days post infection with dengue virus), we tested three translational doses (5.8 \u03bcg\/kg, 28 \u03bcg\/kg, and 140 \u03bcg\/kg). Dose- and time-dependent inhibition of the viral copy numbers was identified upon Denguenil Vati treatment. Hepatocyte necrosis, liver inflammation, and red blood cell (RBC) infiltration into the liver were significantly inhibited upon Denguenil treatment. Treatment with Denguenil Vati significantly recovered the virus-induced decreases in total platelet numbers and total RBC count, and concomitantly increasing hematocrit percentage, in a dose- and time-dependent manner. Conversely, virus-induced white blood cell (WBC) counts were significantly normalized. Virus-induced hemorrhage was completely abrogated by Denguenil after 14 days, at all the doses tested. Gene expression analysis identified a significant decrease in disease-induced endothelial apoptotic marker Angiopoetin2 (Ang-2) and pro-inflammatory chemokine marker CCL3 upon Denguenil treatment. Presence of gallic acid, ellagic acid, palmetin, and berberine molecules in the Denguenil formulation was detected by HPLC. Taken together, our results exhibit the potential therapeutic properties of Denguenil Vati in ameliorating pathological features of dengue.<\/jats:p>","DOI":"10.3390\/biom10070971","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T09:36:04Z","timestamp":1593509764000},"page":"971","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Validation of a Novel Zebrafish Model of Dengue Virus (DENV-3) Pathology Using the Pentaherbal Medicine Denguenil Vati"],"prefix":"10.3390","volume":"10","author":[{"given":"Acharya","family":"Balkrishna","sequence":"first","affiliation":[{"name":"Drug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar 249 405, Uttarakhand, India"},{"name":"Department of Allied and Applied Sciences, University of Patanjali, Patanjali Yog Peeth, Roorkee-Haridwar Road, Haridwar 249 405, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva Kumar","family":"Solleti","sequence":"additional","affiliation":[{"name":"Drug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar 249 405, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep","family":"Verma","sequence":"additional","affiliation":[{"name":"Drug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar 249 405, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8509-0882","authenticated-orcid":false,"given":"Anurag","family":"Varshney","sequence":"additional","affiliation":[{"name":"Drug Discovery and Development Division, Patanjali Research Institute, NH-58, Haridwar 249 405, Uttarakhand, India"},{"name":"Department of Allied and Applied Sciences, University of Patanjali, Patanjali Yog Peeth, Roorkee-Haridwar Road, Haridwar 249 405, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,28]]},"reference":[{"key":"ref_1","unstructured":"WHO (2012). Global Strategy for Dengue Prevention and Control 2012\u20132020. World Health Organiszation, WHO."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"ref_3","unstructured":"(2020, May 05). Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases, Available online: https:\/\/www.cdc.gov\/dengue\/about\/index.html."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Brady, O.J., Gething, P.W., Bhatt, S., Messina, J.P., Brownstein, J.S., Hoen, A.G., Moyes, C.L., Farlow, A.W., Scott, T.W., and Hay, S.I. (2012). Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001760"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(14)60572-9","article-title":"Dengue","volume":"385","author":"Guzman","year":"2015","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri3014","article-title":"Immunity to dengue virus: A tale of original antigenic sin and tropical cytokine storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.tim.2010.04.003","article-title":"Targeting a host process as an antiviral approach against dengue virus","volume":"18","author":"Sayce","year":"2010","journal-title":"Trends Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue","volume":"370","author":"Halstead","year":"2007","journal-title":"Lancet"},{"key":"ref_9","unstructured":"WHO (2013). Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control 2009, WHO."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"164878","DOI":"10.1155\/2010\/164878","article-title":"Cells in dengue virus infection in vivo","volume":"2010","author":"Noisakran","year":"2010","journal-title":"Adv. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/clinids\/11.Supplement_4.S826","article-title":"Hemostatic Defects in Dengue Hemorrhagic Fever","volume":"11","author":"Bhamarapravati","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jmb.2013.11.023","article-title":"Innate immunity to dengue virus infection and subversion of antiviral responses","volume":"426","author":"Green","year":"2014","journal-title":"J. Mol. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/JVI.73.5.3623-3629.1999","article-title":"Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones","volume":"73","author":"Gagnon","year":"1999","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Tolfvenstam, T., Lindblom, A., Schreiber, M.J., Ling, L., Chow, A., Ooi, E.E., and Hibberd, M.L. (2011). Characterization of early host responses in adults with dengue disease. BMC Infect. Dis., 11.","DOI":"10.1186\/1471-2334-11-209"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/128.1.23","article-title":"Studies on the pathogenesis of dengue infection in monkeys. III. sequential distribution of virus in primary and heterologous infections","volume":"128","author":"Marchette","year":"1973","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/infdis\/128.1.7","article-title":"Studies on the pathogenesis of dengue infection in monkeys. I. clinical laboratory responses to primary infection","volume":"128","author":"Halstead","year":"1973","journal-title":"J. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood-2009-09-242990","article-title":"Dengue virus\u2014Induced hemorrhage in a nonhuman primate model","volume":"115","author":"Onlamoon","year":"2010","journal-title":"Blood"},{"key":"ref_18","first-page":"146","article-title":"Susceptibility of laboratory-bred rodent to the experimental infection with dengue virus type 2","volume":"40","author":"Raut","year":"1996","journal-title":"Acta Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.virol.2005.04.042","article-title":"Liver injury and viremia in mice infected with dengue-2 virus","volume":"338","author":"Paes","year":"2005","journal-title":"Virology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/v4010062","article-title":"Animal models of dengue virus infection","volume":"4","author":"Zompi","year":"2012","journal-title":"Viruses"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Krishnakumar, V., Durairajan, S.S.K., Alagarasu, K., Li, M., and Dash, A.P. (2019). Recent updates on mouse models for human immunodeficiency, influenza, and dengue viral infections. Viruses, 11.","DOI":"10.3390\/v11030252"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2014.04.014","article-title":"Through the looking glass: Witnessing host-virus interplay in zebrafish","volume":"22","author":"Levraud","year":"2014","journal-title":"Trends Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2016.12.013","article-title":"Modelling viral infections using zebrafish: Innate immune response and antiviral research","volume":"139","author":"Varela","year":"2017","journal-title":"Antiviral Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fneur.2018.00347","article-title":"Zebrafish as an animal model for drug discovery in Parkinson\u2019s disease and other movement disorders: A systematic review","volume":"9","author":"Vaz","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fgene.2018.00348","article-title":"Rare genetic blood disease modeling in zebrafish","volume":"9","author":"Rissone","year":"2018","journal-title":"Front. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.2217\/fmb.15.105","article-title":"Dengue: An update on treatment options","volume":"10","author":"Chan","year":"2015","journal-title":"Future Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/infdis\/jiw068","article-title":"Dengue Vaccine: The Need, the Challenges, and Progress","volume":"214","author":"Rothman","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/2225-4110.124335","article-title":"Antiviral natural products and herbal medicines","volume":"4","author":"Lin","year":"2014","journal-title":"J. Tradit. Complement. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nchembio.180","article-title":"Quantifying biogenic bias in screening libraries","volume":"5","author":"Hert","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zandi, K., Teoh, B.T., Sam, S.S., Wong, P.F., Mustafa, M.R., and AbuBakar, S. (2012). Novel antiviral activity of baicalein against dengue virus. BMC Complement. Altern. Med., 12.","DOI":"10.1186\/1472-6882-12-214"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"41864","DOI":"10.1038\/srep41864","article-title":"The citrus flavanone naringenin impairs dengue virus replication in human cells","volume":"7","author":"Frabasile","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lin, L.T., Chen, T.Y., Lin, S.C., Chung, C.Y., Lin, T.C., Wang, G.H., Anderson, R., Lin, C.C., and Richardson, C.D. (2013). Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry. BMC Microbiol., 13.","DOI":"10.1186\/1471-2180-13-187"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0003-9861(68)90654-1","article-title":"Photoperoxidation in isolated chloroplasts. I. Kinetics and stoichiometry of fatty acid peroxidation","volume":"125","author":"Heath","year":"1968","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.reprotox.2014.09.005","article-title":"Comparison of toxicity values across zebrafish early life stages and mammalian studies: Implications for chemical testing","volume":"55","author":"Ducharme","year":"2015","journal-title":"Reprod. Toxicol."},{"key":"ref_36","first-page":"1","article-title":"Interpretation of Animal Dose and Human Equivalent Dose for Drug Development","volume":"31","author":"Shin","year":"2010","journal-title":"J. Korean Orient. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/nyas.12726","article-title":"Angiopoietin-2: A multifaceted cytokine that functions in both angiogenesis and inflammation","volume":"1347","author":"Scholz","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1478-811X-8-11","article-title":"Small molecule screening in zebrafish: An in vivo approach to identifying new chemical tools and drug leads","volume":"8","author":"Taylor","year":"2010","journal-title":"Cell Commun. Signal."},{"key":"ref_39","first-page":"506","article-title":"In silico identification of dengue inhibitors in Giloy (Tinospora cordifolia) and Papaya","volume":"5","author":"Bency","year":"2018","journal-title":"J. Emerg. Technol. Innov. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/10408690490424694","article-title":"Aloe Vera: A Valuable Ingredient for the Food, Pharmaceutical and Cosmetic Industries\u2014A Review","volume":"44","author":"Eshun","year":"2004","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jep.2007.01.008","article-title":"Hepatoprotective potential of Aloe barbadensis Mill. against carbon tetrachloride induced hepatotoxicity","volume":"111","author":"Chandan","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00705-019-04179-z","article-title":"Evaluation of anti-dengue activity of Carica papaya aqueous leaf extract and its role in platelet augmentation","volume":"164","author":"Sharma","year":"2019","journal-title":"Arch. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S2221-1691(13)60145-8","article-title":"Does Carica papaya leaf-extract increase the platelet count? An experimental study in a murine model","volume":"3","author":"Dharmarathna","year":"2013","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jnutbio.2016.02.003","article-title":"Pomegranate extract and exercise provide additive benefits on improvement of immune function by inhibiting inflammation and oxidative stress in high-fat-diet-induced obesity rats","volume":"32","author":"Zhao","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Houston, D.M.J., Bugert, J.J., Denyer, S.P., and Heard, C.M. (2017). Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when coadministered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0188609"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1196\/annals.1352.015","article-title":"Punica granatum (pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide","volume":"1056","author":"Neurath","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/0973-7847.65323","article-title":"Ocimum sanctum Linn. A reservoir plant for therapeutic applications: An overview","volume":"4","author":"Pattanayak","year":"2010","journal-title":"Pharmacogn. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Tang, L.I.C., Ling, A.P.K., Koh, R.Y., Chye, S.M., and Voon, K.G.L. (2012). Screening of anti-dengue activity in methanolic extracts of medicinal plants. BMC Complement. Altern. Med., 12.","DOI":"10.1186\/1472-6882-12-3"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Cui, Q., Du, R., Anantpadma, M., Schafer, A., Hou, L., Tian, J., Davey, R.A., Cheng, H., and Rong, L. (2018). Identification of ellagic acid from plant rhodiola rosea l. as an anti-ebola virus entry inhibitor. Viruses, 10.","DOI":"10.3390\/v10040152"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1590\/S0074-02762008000500005","article-title":"Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate","volume":"103","author":"Kratz","year":"2008","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/ptr.3101","article-title":"Anti-human rhinovirus activity of gallic acid possessing antioxidant capacity","volume":"24","author":"Choi","year":"2010","journal-title":"Phyther. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/cbdv.200890074","article-title":"Alkaloids from Corydalis saxicola and their anti-hepatitis B virus activity","volume":"5","author":"Li","year":"2008","journal-title":"Chem. Biodivers."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/aps.2016.125","article-title":"Advances in the study of berberine and its derivatives: A focus on anti-inflammatory and anti-tumor effects in the digestive system","volume":"38","author":"Zou","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2015.12.012","article-title":"Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses","volume":"126","author":"Varghese","year":"2016","journal-title":"Antiviral Res."},{"key":"ref_55","first-page":"390","article-title":"Dengue: A review of the laboratory tests a clinician must know to achieve a correct diagnosis","volume":"8","author":"Fonseca","year":"2004","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/beha.2000.0073","article-title":"Haematology in dengue and dengue haemorrhagic fever","volume":"13","author":"Srichaikul","year":"2000","journal-title":"Bailliere\u2019s Best Pract. Res. Clin. Haematol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/0003-4819-62-5-867","article-title":"Hematodepressive Virus Diseases of Thailand","volume":"62","author":"Bierman","year":"1965","journal-title":"Ann. Intern. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ddmod.2006.03.014","article-title":"Models of dengue virus infection","volume":"3","author":"Bente","year":"2006","journal-title":"Drug Discov. Today Dis. Model."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.trstmh.2005.10.007","article-title":"Pathogenesis of liver involvement during dengue viral infections","volume":"100","author":"Seneviratne","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.antiviral.2017.02.003","article-title":"JNK1\/2 inhibitor reduces dengue virus-induced liver injury","volume":"141","author":"Sreekanth","year":"2017","journal-title":"Antiviral Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.virusres.2014.03.025","article-title":"Role of ERK1\/2 signaling in dengue virus-induced liver injury","volume":"188","author":"Sreekanth","year":"2014","journal-title":"Virus Res."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Sreekanth, G.P., Chuncharunee, A., Sirimontaporn, A., Panaampon, J., Noisakran, S., Yenchitsomanus, P.T., and Limjindaporn, T. (2016). SB203580 modulates p38 MAPK signaling and Dengue virus-induced liver injury by reducing MAPKAPK2, HSP27, and ATF2 phosphorylation. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149486"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s004280000329","article-title":"Liver histopathology and biological correlates in five cases of fatal dengue fever in Vietnamese children","volume":"438","author":"Huerre","year":"2001","journal-title":"Virchows Arch."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/infdis\/jis470","article-title":"A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in Adult dengue patients","volume":"207","author":"Nguyen","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1073\/pnas.0907010106","article-title":"An adenosine nucleoside inhibitor of dengue virus","volume":"106","author":"Yin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1128\/JVI.74.4.1794-1800.2000","article-title":"The RNA Helicase and Nucleotide Triphosphatase Activities of the Bovine Viral Diarrhea Virus NS3 Protein Are Essential for Viral Replication","volume":"74","author":"Gu","year":"2000","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/BSR20100142","article-title":"Dengue protease activity: The structural integrity and interaction of NS2B with NS3 protease and its potential as a drug target","volume":"31","author":"Phong","year":"2011","journal-title":"Biosci. Rep."},{"key":"ref_68","unstructured":"Leangpibul, P., and Thongcharoen, P. (1993). Monograph on dengue\/dengue haemorrhagic fever. World Health Organization. No. Regional Publication No. 22, WHO Regional Office for South-East Asia."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Lam, P.K., Ngoc, T.V., Thu Thuy, T.T., Hong Van, N.T., Nhu Thuy, T.T., Hoai Tam, D.T., Dung, N.M., Hanh Tien, N.T., Thanh Kieu, N.T., and Simmons, C. (2017). The value of daily platelet counts for predicting dengue shock syndrome: Results from a prospective observational study of 2301 Vietnamese children with dengue. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005498"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jviromet.2004.06.013","article-title":"In vitro assessment of human endothelial cell permeability: Effects of inflammatory cytokines and dengue virus infection","volume":"121","author":"Dewi","year":"2004","journal-title":"J. Virol. Methods"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Mapalagamage, M., Handunnetti, S.M., Wickremasinghe, A.R., Premawansa, G., Thillainathan, S., Fernando, T., Kanapathippillai, K., de Silva, A.D., and Premawansa, S. (2020). High levels of serum angiopoietin 2 and angiopoietin 2\/1 ratio at the critical stage of dengue hemorrhagic fever in patients and association with clinical and biochemical parameters. J. Clin. Microbiol., 58.","DOI":"10.1128\/JCM.00436-19"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/imm.12748","article-title":"Pathogenesis of vascular leak in dengue virus infection","volume":"151","author":"Malavige","year":"2017","journal-title":"Immunology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12929-015-0191-6","article-title":"Biomarkers of severe dengue disease\u2014A review","volume":"22","author":"John","year":"2015","journal-title":"J. Biomed. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/labinvest.3700325","article-title":"Increased angiopoietin2 expression is associated with endothelial apoptosis and blood-brain barrier breakdown","volume":"85","author":"Nag","year":"2005","journal-title":"Lab. Investig."},{"key":"ref_75","first-page":"113","article-title":"Dengue infection in Lao PDR","volume":"45","author":"Soukaloun","year":"2014","journal-title":"Southeast. Asian J. Trop. Med. Public Health"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Guabiraba, R., Marques, R.E., Besnard, A.G., Fagundes, C.T., Souza, D.G., Ryffel, B., and Teixeira, M.M. (2010). Role of the Chemokine Receptors CCR1, CCR2 and CCR4 in the Pathogenesis of Experimental Dengue Infection in Mice. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0015680"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/jmv.2037","article-title":"MIP-1\u03b1 and MIP-1\u03b2 induction by dengue virus","volume":"65","author":"Lok","year":"2001","journal-title":"J. Med. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0065-3527(03)60010-2","article-title":"Immunology and Immunopathogenesis of Dengue Disease","volume":"60","author":"Rothman","year":"2003","journal-title":"Adv. Virus Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.0300-9475.2004.01519.x","article-title":"Gene expression in human macrophages infected with dengue virus serotype-2","volume":"60","author":"Romano","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1590\/S0074-02762010000300010","article-title":"Virucidal activity of Colombian Lippia essential oils on dengue virus replication in vitro","volume":"105","author":"Ocazionez","year":"2010","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1876518101002020049","article-title":"Development of New Antiviral Agents from Natural Products","volume":"2","author":"Kurokawa","year":"2010","journal-title":"Open Antimicrob. Agents J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1186\/1743-422X-8-560","article-title":"Antiviral activity of four types of bioflavonoid against dengue virus type-2","volume":"8","author":"Zandi","year":"2011","journal-title":"Virol. J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3851\/IMP1884","article-title":"Narasin, a novel antiviral compound that blocks dengue virus protein expression","volume":"16","author":"Low","year":"2011","journal-title":"Antivir. Ther."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/10\/7\/971\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:43:54Z","timestamp":1760175834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/10\/7\/971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,28]]},"references-count":83,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["biom10070971"],"URL":"https:\/\/doi.org\/10.3390\/biom10070971","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,28]]}}}